News in brief: Epsilon launches biotech arm; LGP sells WA facility for $7.8m; Neurotech partners with University of Sydney on Rett program by Adam Sheldon February 18, 2026June 8, 2026 Epsilon Healthcare has established a new subsidiary, Epsilon Biotech, which the firm said would accelerate its […]
Cannatrek ‘evolution’ key to merger, says LGP managing director by Adam Sheldon February 3, 2026February 5, 2026
European growth helps LGP report record quarter of revenue by Steve Jones January 30, 2026February 3, 2026
French medicinal cannabis transition stalls as pilot extended into 2026 by Adam Sheldon January 27, 2026January 27, 2026
Cannatrek deal driven by ‘critical’ need to maintain margins, says LGP boss by Steve Jones January 19, 2026January 19, 2026
Cannatrek in reverse takeover of LGP as firms announce ‘transformational merger’ by Steve Jones January 14, 2026January 15, 2026
Federal Court backs funding bid as liquidators pursue $22m owed to Melodiol creditors by Adam Sheldon December 8, 2025February 21, 2026
Compliance gaps, slow licensing and strict rules put Australia at risk on global stage, expert warns by Adam Sheldon November 26, 2025November 26, 2025
LGP having ‘positive’ discussions after taking ‘proactive’ approach to M&A by Adam Sheldon November 13, 2025November 17, 2025
